Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Respiratory Syncytial Virus Prevention”

40 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 40 results

Large-scale testing (Phase 3)Ended earlyNCT05242432
What this trial is testing

Adenovirus Serotype 26.Respiratory Syncytial Virus.Pre-Fusion F (Ad26.RSV.preF)-Based Vaccine for Prevention of Respiratory Syncytial Virus (RSV) Mediated- Lower Respiratory Tract Disease (LRTD) in Japanese Participants

Who this might be right for
Respiratory Syncytial Virus Prevention
Janssen Pharmaceutical K.K. 2,192
Early research (Phase 1)Study completedNCT05970744
What this trial is testing

Evaluation of RSV/Flu-01E Vaccine for the Prevention of RSV Infection in Volunteers Aged 18 to 59 Years and Over 60 Years

Who this might be right for
Respiratory Syncytial Virus Infections
Tatyana Zubkova 60
Not applicableStudy completedNCT07177508
What this trial is testing

First Year Impact of Nirsevimab on Paediatric Respiratory Syncytial Virus Infection and Hospitalisations in the Australian Capital Territory

Who this might be right for
Respiratory Syncytial Viral (RSV) InfectionRespiratory Syncytial Virus HospitalizationsRespiratory Syncytial Virus Prevention
Nicola Irwin 2,355
Post-approval studies (Phase 4)Study completedNCT00001903
What this trial is testing

Prevention of RSV Infections in Bone Marrow Transplant Recipients

Who this might be right for
Respiratory Syncytial Virus Infection
National Institute of Allergy and Infectious Diseases (NIAID) 120
Not applicableLooking for participantsNCT06881953
What this trial is testing

Prevention Strategy for Respiratory Syncytial Virus (RSV) Infections in Infants in France

Who this might be right for
RSV Infection
Assistance Publique - Hôpitaux de Paris 400
Early research (Phase 1)Study completedNCT06237296
What this trial is testing

Study of the Safety and Immune Response of an Investigational mRNA Vaccine for the Prevention of Respiratory Syncytial Virus and/or Human Metapneumovirus in Participants Aged 18 to 49 Years and 60 Years and Older

Who this might be right for
Respiratory Syncytial Virus InfectionHealthy VolunteersMetapneumovirus Infection
Sanofi Pasteur, a Sanofi Company 558
Early research (Phase 1)Study completedNCT00192504
What this trial is testing

Safety Study of a Monoclonal Antibody to Respiratory Syncytial Virus (RSV) in Children Hospitalized With RSV Infection

Who this might be right for
Respiratory Syncytial Virus Prophylaxis
MedImmune LLC 31
Not applicableNot Yet RecruitingNCT07164430
What this trial is testing

The Impact of the 2025 Infant and Maternal Respiratory Syncytial Virus (RSV) Prevention Program on RSV-related Hospitalisations in the Australian Capital Territory

Who this might be right for
Respiratory Syncytial Virus (RSV) InfectionRespiratory Syncytial Virus HospitalizationsRespiratory Syncytial Virus Immunization
Nicola Irwin 2,100
Early research (Phase 1)Active Not RecruitingNCT06556147
What this trial is testing

RSV-HMPV Bivalent Vaccine VXB-241 in Older Adults

Who this might be right for
Healthy Volunteers
Vicebio Australia Proprietary Limited 144
Testing effectiveness (Phase 2)Ended earlyNCT02508194
What this trial is testing

Evaluate the Efficacy of MEDI7510 in Older Adults

Who this might be right for
Respiratory Syncytial Virus
MedImmune LLC 1,900
Early research (Phase 1)Study completedNCT06583031
What this trial is testing

Study to Evaluate the Safety and Immune Response of an Investigational Vaccine for the Prevention of RSV (Respiratory Syncytial Virus) and (hMPV) Human Metapneumovirus Infection in Participants Aged 60 to 75 Years

Who this might be right for
RSV InfectionhMPV
Sanofi Pasteur, a Sanofi Company 385
Not applicableStudy completedNCT00384462
What this trial is testing

Study to Evaluate the Incidence of Hospitalizations and Respiratory Tract Infections in Premature Infants

Who this might be right for
Respiratory Syncytial Virus Infections
MedImmune LLC 346
Large-scale testing (Phase 3)Study completedNCT03979313
What this trial is testing

Evaluate the Safety and Efficacy of MEDI8897 for the Prevention of Medically Attended Lower Respiratory Tract Infection Due to Respiratory Syncytial Virus in Healthy Late Preterm and Term Infants (MELODY)

Who this might be right for
Respiratory Syncytial Virus Infections
AstraZeneca 3,012
Large-scale testing (Phase 3)Study completedNCT05083585
What this trial is testing

A Study Evaluating the Immunogenicity of Different Clinical Trial Materials of Ad26.RSV.preF- Based Vaccine in Adults Aged 60 - 75 Years Old

Who this might be right for
Respiratory Syncytial Virus Prevention
Janssen Vaccines & Prevention B.V. 250
Large-scale testing (Phase 3)Not Yet RecruitingNCT07232706
What this trial is testing

Prevention of RSV Infection in Infants by Administering Nirsevimab to Infants, With or Without Maternal RSV Vaccination

Who this might be right for
RSV Immunization
Centre Hospitalier Annecy Genevois 1,000
Testing effectiveness (Phase 2)Ended earlyNCT05327816
What this trial is testing

Various Respiratory Syncytial Virus (RSV) Pre-Fusion (preF)-Based Vaccine Formulations in Adults Aged 60 Years and Older

Who this might be right for
Respiratory Syncytial Virus-associated Lower Respiratory Tract Disease Prevention
Janssen Vaccines & Prevention B.V. 132
Not applicableStudy completedNCT01545245
What this trial is testing

Effects of Preventive Treatment for Respiratory Syncytial (RS) Virus Infection During Infancy on Later Atopic Asthma in Preterm Infants

Who this might be right for
Atopic AsthmaRecurrent Wheezing
Tokai University 343
Testing effectiveness (Phase 2)Study completedNCT02878330
What this trial is testing

Evaluate the Safety and Efficacy of MEDI8897 for the Prevention of Medically Attended RSV LRTI in Healthy Preterm Infants.

Who this might be right for
Respiratory Syncytial Virus Infections
MedImmune LLC 1,453
Large-scale testing (Phase 3)Study completedNCT05101486
What this trial is testing

An Ad26.RSV.PreF-based Regimen at the End of Shelf-life in Adults Aged 60 to 75 Years

Who this might be right for
Respiratory Syncytial Virus Prevention
Janssen Vaccines & Prevention B.V. 755
Large-scale testing (Phase 3)Study completedNCT01006629
What this trial is testing

Palivizumab for Prevention of Severe Respiratory Syncytial Virus Infection in Russian Children

Who this might be right for
Respiratory Syncytial Virus InfectionPremature BirthBronchopulmonary Dysplasia+1 more
Abbott 100
Load More Results